MPCI Statistics

Total Valuation

Memphis Pharmaceuticals & Chemical Industries has a market cap or net worth of EGP 339.19 million. The enterprise value is -1.85 million.

Market Cap	339.19M
Enterprise Value	-1.85M

Important Dates

The next estimated earnings date is Thursday, November 14, 2024.

Earnings Date	Nov 14, 2024
Ex-Dividend Date	n/a

Share Statistics

Memphis Pharmaceuticals & Chemical Industries has 5.63 million shares outstanding.

Shares Outstanding	5.63M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	1.77M

Valuation Ratios

The trailing PE ratio is 1.77.

PE Ratio	1.77
Forward PE	n/a
PS Ratio	0.39
PB Ratio	2.28
P/FCF Ratio	2.14
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-0.01
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-0.01

Financial Position

The company has a current ratio of 1.16, with a Debt / Equity ratio of 1.20.

Current Ratio	1.16
Quick Ratio	0.90
Debt / Equity	1.20
Debt / EBITDA	0.90
Debt / FCF	1.13
Interest Coverage	13.01

Financial Efficiency

Return on equity (ROE) is 150.74% and return on invested capital (ROIC) is 51.96%.

Return on Equity (ROE)	150.74%
Return on Assets (ROA)	11.58%
Return on Capital (ROIC)	51.96%
Revenue Per Employee	6.05M
Profits Per Employee	1.33M
Employee Count	144
Asset Turnover	0.87
Inventory Turnover	2.41

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -5.90% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-5.90%
50-Day Moving Average	37.17
200-Day Moving Average	75.19
Relative Strength Index (RSI)	84.61
Average Volume (20 Days)	154,362

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Memphis Pharmaceuticals & Chemical Industries had revenue of EGP 871.91 million and earned 191.46 million in profits. Earnings per share was 34.04.

Revenue	871.91M
Gross Profit	298.49M
Operating Income	185.47M
Pretax Income	229.52M
Net Income	191.46M
EBITDA	197.65M
EBIT	185.47M
Earnings Per Share (EPS)	34.04

Full Income Statement

Balance Sheet

The company has 519.86 million in cash and 178.82 million in debt, giving a net cash position of 341.04 million or 60.63 per share.

Cash & Cash Equivalents	519.86M
Total Debt	178.82M
Net Cash	341.04M
Net Cash Per Share	60.63
Equity (Book Value)	149.08M
Book Value Per Share	26.50
Working Capital	156.56M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 183.21 million and capital expenditures -24.37 million, giving a free cash flow of 158.83 million.

Operating Cash Flow	183.21M
Capital Expenditures	-24.37M
Free Cash Flow	158.83M
FCF Per Share	28.24

Full Cash Flow Statement

Margins

Gross margin is 34.23%, with operating and profit margins of 21.27% and 21.96%.

Gross Margin	34.23%
Operating Margin	21.27%
Pretax Margin	26.32%
Profit Margin	21.96%
EBITDA Margin	22.67%
EBIT Margin	21.27%
FCF Margin	18.22%

Dividends & Yields

This stock pays an annual dividend of 2.00, which amounts to a dividend yield of 3.36%.

Dividend Per Share	2.00
Dividend Yield	3.36%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	2
Payout Ratio	6.35%
Buyback Yield	n/a
Shareholder Yield	3.36%
Earnings Yield	56.45%
FCF Yield	46.83%

Dividend Details

Stock Splits

The last stock split was on May 14, 2009. It was a forward split with a ratio of 1.5.

Last Split Date	May 14, 2009
Split Type	Forward
Split Ratio	1.5

Scores

Memphis Pharmaceuticals & Chemical Industries has an Altman Z-Score of 1.69. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.69
Piotroski F-Score	n/a